Last update 17 Mar 2026

REGEND003

Overview

Basic Info

Drug Type
Cell therapy
Synonyms-
Target-
Action-
Mechanism
Cell replacements
Therapeutic Areas
Endocrinology and Metabolic DiseaseUrogenital DiseasesOther Diseases
Active Indication
Chronic Kidney DiseasesDiabetes Mellitus, Type 2Type 2 diabetes mellitus with established diabetic nephropathy+ [2]
Inactive Indication-
Originator Organization
Regend Therapeutics Co. Ltd.Regend Therapeutics Co. Ltd.
Active Organization
Regend Therapeutics Co. Ltd.Regend Therapeutics Co. Ltd.Regend Therapeutics （ShangHai）Co. Ltd.Regend Therapeutics （ShangHai）Co. Ltd.
Inactive Organization
Meijirui Biotechnology (Wuhan) Co., Ltd.
License Organization-
Drug Highest PhasePhase 1
First Approval Date-
Regulation-
Login to view timeline

Related

2
Clinical Trials associated with REGEND003
NCT07275788
/ RecruitingPhase 1
An Exploratory Study of REGEND003 Kidney Progenitor Cells on Patients With Type 2 Diabetes Mellitus (T2DM) and Chronic Kidney Disease (CKD)
ChiCTR2500112411
/ Not yet recruitingPhase 1IIT
An Exploratory Study of REGEND003 Kidney Progenitor Cells on Patients With Type 2 Diabetes Mellitus (T2DM) and Chronic Kidney Disease (CKD)
100 Clinical Results associated with REGEND003
Login to view more data
100 Translational Medicine associated with REGEND003
Login to view more data
100 Patents (Medical) associated with REGEND003
Login to view more data
100 Deals associated with REGEND003
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Chronic Kidney DiseasesPhase 1
China
Regend Therapeutics Co. Ltd.Regend Therapeutics Co. Ltd.
08 Jan 2026
Diabetes Mellitus, Type 2Phase 1
China
Regend Therapeutics Co. Ltd.Regend Therapeutics Co. Ltd.
08 Jan 2026
Type 2 diabetes mellitus with established diabetic nephropathyPhase 1
China
Meijirui Biotechnology (Wuhan) Co., Ltd.
09 Jul 2025
Diabetic NephropathiesPreclinical
China
Regend Therapeutics Co. Ltd.Regend Therapeutics Co. Ltd.
04 Mar 2022
FibrosisPreclinical
China
Regend Therapeutics Co. Ltd.Regend Therapeutics Co. Ltd.
04 Mar 2022
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free